Created with Sketch.
21 minutes | 12 days ago
Peptide Receptor Radionuclide Therapy (PRRT): What Surgeons Need to Know
In this episode of SurgOnc Today™, Gastrointestinal Disease Site Work Group Chair, Vance Sohn, MD, discusses PRRT with SSO President, James Howe, MD and Thomas Clancy, MD from the Gastrointestinal Disease Site Work Group. They discuss the current indications, efficacy, and what the future holds for PRRT.
27 minutes | 16 days ago
HPB Incidentalomas Part 1: Liver and Biliary
In this episode, Melissa Hogg, MD, Chair of the Hepato-Pancreato-Biliary Disease Site Work Group and disease site work group members Jin He, MD, PhD, and H.J. Kim, MD, discuss the common and mostly benign imaging findings of the liver and biliary system with a focus on indications for surveillance, surgery, or additional necessary work-up.
24 minutes | 21 days ago
The Role of Neoadjuvant Radiation in Retroperitoneal Sarcomas – Changing Practice Based on Results of the STRASS Trial
The recently published EORTC 62092 trial (STRASS) examines abdominal recurrence in patients after surgical resection of retroperitoneal sarcomas. This randomized study compared these recurrences in patients receiving neoadjuvant radiation versus those undergoing surgery alone. Rebecca Gladdy MD, PhD and Ashleigh Guadagnolo, MD join moderator and SSO Sarcoma Disease Site Work Group Chair, Aimee Crago, MD, PhD, to provide insight and analysis from both surgical and radiation oncology perspectives, discussing how this practice-changing trial is altering the approach to patients with these diseases.
27 minutes | 2 months ago
Practice Changing Studies in Hepato-Pancreato-Biliary Surgical Oncology
Alexander Parikh, MD, MPH, Vice Chair of the SSO Hepato-Pancreato-Biliary Disease Site Work Group moderates as Marcus Tan, MD, presents practice changing studies from 2019.
11 minutes | 2 months ago
Practice Changing Studies in Breast Surgical Oncology
Kandace McGuire, MD, Chair of the SSO Breast Disease Site Work Group, moderates as Breast DSWG member Jennifer Plichta, MD, MS, presents practice changing studies from 2019.
28 minutes | 3 months ago
Practice Changing Studies in Melanoma Surgical Oncology
Tina J. Hieken, MD, Vice Chair of the SSO Melanoma Disease Site Work Group, moderates as Melanoma DSWG members, Jessica Cintolo-Gonzalez, MD, and Kelly Olino, MD, present practice changing studies from 2019.
16 minutes | 3 months ago
Practice Changing Studies in Endocrine Surgical Oncology
Anthony Yang, MD, MS, Chair, and Carmen Solorzano, MD, Vice-Chair of the SSO Endocrine Disease Site Work Group, moderate as Linwah Yip, MD, from the Endocrine DSWG presents the following practice-changing studies in endocrine surgical oncology from 2019. Executive Summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, Angelos P, Chen H, Doherty GM, Fahey TJ 3rd, Kebebew E, Livolsi VA, Perrier ND, Sipos JA, Sosa JA, Steward D, Tufano RP, McHenry CR, Carty SE. Ann Surg. 2020 Mar;271(3):399-410. PMID: 32079828 Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features. Suman P, Razdan SN, Wang CE, Tulchinsky M, Ahmed L, Prinz RA, Winchester DJ. J Am Coll Surg. 2020 Jan;230(1):136-144. PMID: 31672668 Five-Year Results of Radiofrequency and Laser Ablation of Benign Thyroid Nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group. Bernardi S, Giudici F, Cesareo R, Antonelli G, Cavallaro M, Deandrea M, Giusti M, Mormile A, Negro R, Palermo A, Papini E, Pasqualini V, Raggiunti B, Rossi D, Sconfienza LM, Solbiati L, Spiezia S, Tina D, Vera L, Stacul F, Mauri G. Thyroid. 2020 Jul 24. PMID: 32578498 Clinical Presentation, Treatment, and Outcome of Parathyroid Carcinoma: Results of the NEKAR Retrospective International Multicenter Study. Lenschow C, Schrägle S, Kircher S, Lorenz K, Machens A, Dralle H, Riss P, Scheuba C, Pfestroff A, Spitzweg C, Zielke A, Nießen A, Dotzenrath C, Riemann B, Quinkler M, Vorländer C, Zahn A, Raue F, Chiapponi C, Iwen KA, Steinmüller T, Kroiss M, Schlegel N; NEKAR study group. Ann Surg. 2020 Jul 7. PMID: 32649472 Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma. Assié G, Jouinot A, Fassnacht M, Libé R, Garinet S, Jacob L, Hamzaoui N, Neou M, Sakat J, de La Villéon B, Perlemoine K, Ragazzon B, Sibony M, Tissier F, Gaujoux S, Dousset B, Sbiera S, Ronchi CL, Kroiss M, Korpershoek E, De Krijger R, Waldmann J, Quinkler M, Haissaguerre M, Tabarin A, Chabre O, Luconi M, Mannelli M, Groussin L, Bertagna X, Baudin E, Amar L, Coste J, Beuschlein F, Bertherat J.JAMA Oncol. 2019 Jul 11;5(10). PMID: 31294750
23 minutes | 5 months ago
Cancer Network Affiliations: Implications and Opportunities for Cancer Care Quality
Lesly Dossett, MD interviews Dan Boffa, MD about his work exploring the rationale and potential advantages of cancer networks, while also reviewing the data on patient perceptions and surgical quality within cancer networks.
16 minutes | 6 months ago
Opioid Optimization in Surgical Oncology: Lessons Learned, Tips and Tricks, and Advancing Post-Operative Care
Join moderator Vance Sohn, MD and his guests Sarah DeSnyder, MD and Ching-Wei Tzeng, MD from the MD Anderson Cancer Center as they resume their conversation on opioid optimization. These experts will discuss lessons learned in advancing post-operative pain management as well as practical tips on how to implement optimization pathways.
13 minutes | 6 months ago
Opioid Optimization in Surgical Oncology: Innovations in the Outpatient and Inpatient Settings
Join moderator Vance Sohn, MD and his guests Sarah DeSnyder, MD and Ching-Wei Tzeng, MD from the MD Anderson Cancer Center as they discuss the important role that surgical oncologists play in post-operative opioid optimization. Learn about innovative ways being implemented in the outpatient and inpatient settings that are leading to safer, patient-centered, post-operative pain management.
23 minutes | 6 months ago
Navigating the Resumption of Breast Cancer Surgery During COVID-19
SSO Secretary, Kelly Hunt, MD interviews Mehra Golshan, MD, and Eleftherios (Terry) Mamounas, MD, about their involvement with the manuscript, “COVID-19 Pandemic Breast Cancer Consortium’s Considerations for Re-Entry.” Dr. Golshan and Dr. Mamounas were appointed as SSO representatives to a consortium consisting of experts from The American Society of Breast Surgeons, the National Accreditation Program for Breast Centers, the National Comprehensive Cancer Network, the American College of Surgeons Commission on Cancer, the American College of Radiology and the American Society of Clinical Oncology.
16 minutes | 6 months ago
The Surgical Oncologist as a COVID-19 Patient: From Diagnosis to Recovery
SSO President, James Howe, MD, interviews George Chang, MD, MD Anderson Cancer Center, about his experience being diagnosed with and recovering from COVID-19. Dr. Howe and Dr. Chang discussed symptoms, testing, his hospitalization, returning to work and Dr. Chang’s experience donating his plasma to help give others passive immunity.
24 minutes | 7 months ago
Axillary Management After Neoadjuvant Therapy in Hormone Receptor Positive Breast Cancer
In this episode of SurgOnc Today™, Armando Giuliano, MD, Tari King, MD and Melissa Pilewskie, MD, discuss the management of the axilla after preoperative systemic therapy. Evaluation of the axilla pre- and post chemotherapy along with surgical management is discussed in a case with a 3 cm, poorly differentiated invasive ductal carcinoma.
30 minutes | 7 months ago
The Choice of Neoadjuvant Therapy for Hormone Receptor Positive Breast Cancer
In this episode of SurgOnc Today™, Armando Giuliano, MD, Tari King, MD and Otto Metzger, MD, discuss the choice between preoperative endocrine therapy and preoperative chemotherapy in hormone receptor positive breast cancer patients. Evaluation and treatment is discussed for a post-menopausal woman presenting a 3.4 cm node negative, invasive ductal carcinoma
14 minutes | 8 months ago
Practice Changing Studies in GI Surgical Oncology 2019
In this episode of SurgOnc Today, Ajay Maker, MD, Director of Surgical Oncology at AIMMC/Creticos Cancer Center at the University of Illinois at Chicago, interviews SSO Gastrointestinal Disease Site Work Group members about the most influential papers in GI surgical oncology from 2019. Four conversations cover topics including: A recent Lancet study about combination chemotherapy for pancreatic cancer Advanced gastric cancer and perioperative chemotherapy regimens New therapies for metastatic gastric cancer An Annals of Surgical Oncology paper about diagnosing GI cancers from circulating tumor DNA Ajay Maker, MD, is the Director of Surgical Oncology at AIMMC/Creticos Cancer Center, and Associate Professor in the Department of Surgery, Division of Surgical Oncology at the University of Illinois at Chicago Evan S. Glazer, MD, PhD, is Assistant Professor of Surgery and Principal Investigator, Center for Cancer Research at the University of Tennessee Health Science Center Yanghee Woo, MD, is Director, Gastroenterology Minimally Invasive Therapy Program and Associate Clinical Professor, Division of Surgical Oncology, Department of Surgery at City of Hope Mio Kitano, MD, is Assistant Professor in the Division of Surgical Oncology and Endocrine Surgery at the University of Texas Health San Antonio Carlos Chan, MD, PhD, is Assistant Professor of Surgery, Director-Molecular Epidemiology Resource Core, Assistant Professor of Radiation Oncology, Assistant Professor of Surgery, Surgical Oncology and Endocrine Surgery at the University of Iowa
5 minutes | 8 months ago
Endocrine Cancer Surgical Perspectives during COVID-19
SSO President-Elect, James R. Howe, MD provides various perspectives on endocrine cancers and COVID-19. Dr. Howe is the Director, Surgical Oncology and Endocrine Surgery at the Roy J. and Lucille A. Carver University of Iowa College of Medicine, Iowa City, IA.
10 minutes | 8 months ago
Breast Cancer Surgical Perspectives During COVID-19
SSO President-Elect, James R. Howe, MD, speaks with SSO Breast Cancer Disease Site Work Group Vice Chair, Kandace P. McGuire, MD. Dr. McGuire is the Chief, Section of Breast Surgery at the Massey Cancer Center at Virginia Commonwealth University, Richmond, VA.
8 minutes | 8 months ago
Melanoma Surgical Perspectives during COVID-19
SSO President-Elect, James R. Howe, MD provides speaks with SSO Melanoma Disease Site Work Group Chair, Giorgos C. Karakousis, MD. Dr. Karakousis is an Associate Professor of Surgery at the Abramson Cancer Center University of Pennsylvania, Philadelphia, PA.
8 minutes | 8 months ago
GI and HPB Cancer Surgical Perspectives During COVID-19
SSO President, David L. Bartlett, MD speaks with SSO HPB Disease Site Work Group Vice Chair, Melissa E. Hogg, MD, MS. Dr. Hogg is the Director of HPB Surgery, Director of Robotic Training for Grainger Labs and Northshore University Healthsystem, Evanston, IL.
8 minutes | 8 months ago
Colorectal Cancer Surgical Perspectives during COVID-19
SSO President, David L. Bartlett, MD speaks with SSO Colorectal Disease Site Work Group Chair, George J. Chang, MD, MS. Dr. Chang is the Deputy Department Chair, Department of Surgical Oncology, Division of Surgery, Chief, Section of Colon and Rectal Surgery at The University of Texas MD Anderson Cancer Center, Houston, TX.
Terms of Service
© Stitcher 2020